로딩 중…
StockDiggingStockDigging

Phreesia, Inc.

PHR· NYSE
$12.44+0.00%
2026-11-02

Financials

Valuation Metrics

Phreesia, Inc.'s Market Cap is $768M. At end of 2025 it was $1.01B. Ranked #2557 of 3,118 in US market (top 82%), #1483 of 1,644 on NYSE (top 90%), #165 of 203 in Health Care Equipment & Services (top 81%) by Market Cap.

Investment Metrics(as of 2026-11-02)

MetricValue
Size
Market Cap$768M
Revenue$508M
Net Income$10M
Total Assets$647M
Net Assets$372M
Employees1,789
Value
P/E73.56x
P/B2.07x
P/S1.51x
EV/EBITDA13.55x
FCF Yield10.09%
Profitability
ROE2.81%
ROA1.61%
Op. Margin3.19%
Revenue Growth12.93%
Financial Health
Debt Ratio73.99%
Total Debt$68M
FCF$78M
Cash$73M
Current Ratio1.76x
Net Debt/EBITDA-0.09x
Performance
1Y Return-45.05%
1M Return23.54%
From 52W High-46.63%
1Y MDD-65.18%
Trading
Volume482,845 shares
Trading Value$6M
Per Share
EPS$0.17
BPS$6.02

Company Info

CEO Chaim Indig
Employees 1,789
HQ Wilmington, US

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.